▶ 調査レポート

消化管間質腫瘍(GIST)治療の世界市場:市場規模・現状・予測

• 英文タイトル:Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。消化管間質腫瘍(GIST)治療の世界市場:市場規模・現状・予測 / Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size, Status and Forecast 2019-2025 / QYR9ST03640資料のイメージです。• レポートコード:QYR9ST03640
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、消化管間質腫瘍(GIST)治療の世界市場について調査・分析し、消化管間質腫瘍(GIST)治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他)、用途別(病院、診療所、外来手術センター、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の消化管間質腫瘍(GIST)治療市場動向
・主要企業別マーケットシェア
・消化管間質腫瘍(GIST)治療の種類別市場規模2014-2019
(手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他)
・消化管間質腫瘍(GIST)治療の用途別市場規模2014-2019
(病院、診療所、外来手術センター、その他)
・消化管間質腫瘍(GIST)治療の北米市場:主要企業・種類別/用途別市場規模
・消化管間質腫瘍(GIST)治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・消化管間質腫瘍(GIST)治療の中国市場:主要企業・種類別/用途別市場規模
・消化管間質腫瘍(GIST)治療の日本国内市場:主要企業・種類別/用途別市場規模
・消化管間質腫瘍(GIST)治療の東南アジア市場:主要企業・種類別/用途別市場規模
・消化管間質腫瘍(GIST)治療のインド市場:主要企業・種類別/用途別市場規模
・消化管間質腫瘍(GIST)治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Pfizer、Bayer、Novartis、Immunicum、Roche、AB Science、Arog Pharmaceuticals、Boston Biomedical、Sun Pharmaceutical、Natco Pharma)
・消化管間質腫瘍(GIST)治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.In 2018, the global Gastrointestinal Stromal Tumors (GISTs) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gastrointestinal Stromal Tumors (GISTs) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastrointestinal Stromal Tumors (GISTs) Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma

Market segment by Type, the product can be split into
Surgery
Targeted Therapy
Radiation Therapy
Chemotherapy
Ablation
Embolization
Others

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gastrointestinal Stromal Tumors (GISTs) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Gastrointestinal Stromal Tumors (GISTs) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gastrointestinal Stromal Tumors (GISTs) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Targeted Therapy
1.4.4 Radiation Therapy
1.4.5 Chemotherapy
1.4.6 Ablation
1.4.7 Embolization
1.4.8 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size
2.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions (2014-2025)
2.2.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Manufacturers
3.1.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players Head office and Area Served
3.3 Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Product/Solution/Service
3.4 Date of Enter into Gastrointestinal Stromal Tumors (GISTs) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019)
4.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
5.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in United States
5.3 United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
5.4 United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

6 Europe
6.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
6.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Europe
6.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
6.4 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

7 China
7.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
7.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in China
7.3 China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
7.4 China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

8 Japan
8.1 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
8.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Japan
8.3 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
8.4 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
9.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
9.4 Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

10 India
10.1 India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
10.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in India
10.3 India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
10.4 India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2014-2019)
11.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players in Central & South America
11.3 Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
11.4 Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.1.4 Pfizer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.2.4 Bayer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.3.4 Novartis Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Immunicum
12.4.1 Immunicum Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.4.4 Immunicum Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.4.5 Immunicum Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.5.4 Roche Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.5.5 Roche Recent Development
12.6 AB Science
12.6.1 AB Science Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.6.4 AB Science Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.6.5 AB Science Recent Development
12.7 Arog Pharmaceuticals
12.7.1 Arog Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.7.4 Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.7.5 Arog Pharmaceuticals Recent Development
12.8 Boston Biomedical
12.8.1 Boston Biomedical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.8.4 Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.8.5 Boston Biomedical Recent Development
12.9 Sun Pharmaceutical
12.9.1 Sun Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.9.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.9.5 Sun Pharmaceutical Recent Development
12.10 Natco Pharma
12.10.1 Natco Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
12.10.4 Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
12.10.5 Natco Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gastrointestinal Stromal Tumors (GISTs) Treatment Key Market Segments
Table Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Covered
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Market Share by Type 2014-2025
Figure Surgery Figures
Table Key Players of Surgery
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Ablation Figures
Table Key Players of Ablation
Figure Embolization Figures
Table Key Players of Embolization
Figure Others Figures
Table Key Players of Others
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Gastrointestinal Stromal Tumors (GISTs) Treatment Report Years Considered
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2025 (Million US$)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions 2014-2019
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions 2014-2019
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Manufacturers in 2018
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Product/Solution/Service
Table Date of Enter into Gastrointestinal Stromal Tumors (GISTs) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Type (2014-2019)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Market Share by Type (2014-2019)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Application (2014-2019)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Application in 2018
Figure United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Figure Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Figure Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Figure India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Figure Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share (2018-2019)
Table Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2014-2019)
Table Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Bayer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Novartis Recent Development
Table Immunicum Company Details
Table Immunicum Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Immunicum Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Immunicum Recent Development
Table Roche Company Details
Table Roche Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Roche Recent Development
Table AB Science Company Details
Table AB Science Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure AB Science Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table AB Science Recent Development
Table Arog Pharmaceuticals Company Details
Table Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Arog Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Arog Pharmaceuticals Recent Development
Table Boston Biomedical Company Details
Table Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Boston Biomedical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Boston Biomedical Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Natco Pharma Company Details
Table Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)(Million US$)
Figure Natco Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2014-2019)
Table Natco Pharma Recent Development
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Regions (2019-2025)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Regions in 2025
Figure United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Product (2019-2025)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Product in 2025
Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2019-2025)
Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources